Skinbiotherapeutics Plc

Skinbiotherapeutics (SBTX)

Buy
Sell
Company name:Skinbiotherapeutics Plc
Company Description:SkinBioTherapeutics is a life science company focused on skin health.
EPIC:SBTXTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BF33H870
Market Segment:ASQ1Share Type:DE
WWW Address:http://www.skinbiotherapeutics.com/Description:ORD 1P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 17.00 images.advfn.com/imagesnew/2/gb/dot 0.0 [0.00] 16.50 17.50 17.00 17.00 17.00 116,976
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 20.18 118.71 -0.00 -0.94 - - - 27.75 - 5.75

Skinbiotherapeutics Key Figures

(at previous day's close)
Market Cap.20.18m
Shares In Issue118.71m
Prev. Close17.00
PE Ratio- 
Dividend Yield-%
EPS - basic-0.94p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-1.20p
Return On Equity (ROE)-30.13%
Operating Margin-%
PEG Factor- 
EPS Growth Rate-32.39%
Dividends PS Growth Rate-%
Net Debt-3.00m
Gross Gearing3.09%
Quick Assets3.58m
Net Working Capital3.46m
Intangibles / Fixed Assets98.08%
Turnover PS-p
Pre-Tax Profit PS-1.15p
Retained Profit PS-0.97p
Cash PS2.63p
Net Cash PS2.53p
Net Tangible Asset Value PS *2.92p
Net Asset Value PS3.21p
Spread1.00 (5.71%) 

Skinbiotherapeutics Balance Sheet

LSE:SBTX:Liabilities+EQLSE:SBTX:Assets

Share Price Performance

Sample Period HighLow
1 week17.6316.25
4 weeks20.2516.25
12 weeks27.7516.25
1 year27.755.75

Share Price Chart (5 years)

Skinbiotherapeutics Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week17.00--16.250.9717.09
4 weeks18.00-1.00-5.5616.250.7018.01
12 weeks19.75-2.75-13.9216.250.5520.99
26 weeks10.886.1356.3210.130.7318.24
1 year18.50-1.50-8.115.750.5915.50
3 years10.506.5061.905.750.4016.24
5 years13.253.7528.305.750.4115.61

Skinbiotherapeutics Key Management Ratios

Skinbiotherapeutics Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 5.32 
Tobin's Q Ratio (excl. intangibles)5.81 
Dividend Yield-%
Market-to-Book Ratio5.30 
Price-to-Pre-Tax Profit PS-14.83 
Price-to-Retained Profit PS-17.58 
Price-to-Cash Flow PS-14.13 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS5.83 
Price-to-Cash PS6.46 
Net Working Capital PS2.91 
Price Pct to Working Capital PS5.84%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Skinbiotherapeutics Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing-76.40%
Net Gearing (excl. Intangibles)-83.79%
Gross Gearing3.09%
Gross Gearing (excl. Intangibles)3.38%
Gearing Under 1 Year3.09%
Gearing Under 1 Year (excl. Intgbl)3.38%
Assets/Equity1.03 
Cash/Equity82.01 
(Liquidity Ratios)
Net Working Capital to Total Assets87.92%
Current Ratio29.49 
Quick Ratio (Acid Test)29.49 
Liquidity Ratio25.75 
Cash & Equiv/Current Assets87.34%
(Solvency Ratios)
Enterprise Value17.06m
CFO/Sales- 
CFO/Attributable Profit- 
CFO/Assets-0.36 
CFO/Debt-11.77 
Total Debt/Equity Market Value0.01 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit-0.09 
Total Debt0.12m
Total Debt/Net Current Assets0.04%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-5.39%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs1 
Beta (60-Mnth)Beta (36-Mnth)
-0.0013-0.0001

Skinbiotherapeutics Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-35.71%
Return On Assets (ROA)-30.29%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)-30.13%
Return On Investment (ROI)-31.67%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debtors-to-Sales-%
Debt Collection Period-Days

Skinbiotherapeutics Dividends

Sorry No Data Available

Skinbiotherapeutics Fundamentals

 30 Jun 2017 (GBP)30 Jun 2018 (GBP)30 Jun 2019 (GBP)
turnover------m
pre tax profit-0.69--0.94--1.36-m
attributable profit-0.65--0.84--1.15-m
retained profit-0.65--0.84--1.15-m
eps - basic (p)-1.11 -0.71 -0.94 
eps - diluted (p)-1.11 -0.71 -0.94 
dividends per share- - - 

Skinbiotherapeutics Balance Sheet

 30 Jun 2017 (GBP)30 Jun 2018 (GBP)30 Jun 2019 (GBP)
LSE:SBTX:Liabilities+EQLSE:SBTX:AssetsLSE:SBTX:Liabilities+EQLSE:SBTX:AssetsLSE:SBTX:Liabilities+EQLSE:SBTX:Assets
 30 Jun 2017 (GBP)30 Jun 2018 (GBP)30 Jun 2019 (GBP)
ASSETS
fixed assets fixed assets--%--%0.010.17%m
intangibles intangibles0.224.97%0.297.88%0.358.82%m
fixed investments fixed investments--%--%--%m
current assets - other current assets - other0.040.99%--%--%m
stocks stocks--%--%--%m
debtors debtors0.153.49%0.184.92%0.4511.52%m
cash & securities cash & securities3.9290.55%3.1887.20%3.1279.48%m
TOTAL4.33100%3.65100%3.93100%m
LIABILITIES
creditors - short creditors - short0.122.74%0.215.73%0.123.09%m
creditors - long creditors - long--%--%--%m
creditors - other creditors - other--%--%--%m
subordinated loans subordinated loans--%--%--%m
insurance funds insurance funds--%--%--%m
TOTAL0.122.74%0.215.73%0.123.09%m
EQUITY
ord cap, reserves ord cap, reserves4.2197.26%3.4494.27%3.8196.91%m
prefs, minorities prefs, minorities--%--%--%m
TOTAL4.2197.26%3.4494.27%3.8196.91%m
OTHER
NAV Basic- - - 
NAV Diluted- - - 

Skinbiotherapeutics Cash Flow Statement

30 Jun 2017 (GBP)30 Jun 2018 (GBP)30 Jun 2019 (GBP)
Operating CF-0.61-0.67-1.43m
Pre-Financing CF-0.69-0.74-1.50m
Retained CF3.67-0.74-0.06m

Skinbiotherapeutics Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
LSE
SBTX
Skinbiothe..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20201021 11:29:16